These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18212253)

  • 1. Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis.
    Forrest GN; Donovan BJ; Lamp KC; Friedrich LV
    Ann Pharmacother; 2008 Feb; 42(2):213-7. PubMed ID: 18212253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ; Lamp KC
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
    Levine DP; Lamp KC
    Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin use in patients with cancer and neutropenia: data from a retrospective registry.
    Rolston KV; McConnell SA; Brown J; Lamp KC
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):249-56, 90. PubMed ID: 20505648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin in the treatment of bacteremia.
    Sakoulas G; Golan Y; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S21-7. PubMed ID: 17904947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin.
    Beiras-Fernandez A; Kur F; Kiefer S; Sodian R; Schmoeckel M; Weis M; Reichart B; Weis F
    Transplant Proc; 2009; 41(6):2589-91. PubMed ID: 19715980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with daptomycin for the treatment of patients with osteomyelitis.
    Lamp KC; Friedrich LV; Mendez-Vigo L; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S13-20. PubMed ID: 17904946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
    Owens RC; Lamp KC; Friedrich LV; Russo R
    Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation.
    Sakoulas G
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():11-6. PubMed ID: 19917022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with daptomycin treatment of foot or ankle osteomyelitis: a preliminary study.
    Holtom PD; Zalavras CG; Lamp KC; Park N; Friedrich LV
    Clin Orthop Relat Res; 2007 Aug; 461():35-9. PubMed ID: 17549028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin for the treatment of surgical site infections.
    Chamberlain RS; Culshaw DL; Donovan BJ; Lamp KC
    Surgery; 2009 Aug; 146(2):316-24. PubMed ID: 19628091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin - first experiences from the EU-CORE registry study (European Cubicin® Outcomes Registry and Experience)].
    Lübbert C; Wilhelms D; Worlitzsch D; Ettrich TJ; Behl S; Seufferlein T
    Z Gastroenterol; 2012 Apr; 50(4):373-81. PubMed ID: 22430297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of daptomycin in patients receiving hemodialysis.
    Mueller BA; Crompton JA; Donovan BJ; Yankalev S; Lamp KC
    Pharmacotherapy; 2011 Jul; 31(7):665-72. PubMed ID: 21923453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin experience in critical care patients: results from a registry.
    Brown JE; Fominaya C; Christensen KJ; McConnell SA; Lamp KC
    Ann Pharmacother; 2012 Apr; 46(4):495-502. PubMed ID: 22454446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.